Drug intelligence / Profile preview

T2000

Development stage
Unknown
Lead developer
Sun Pharmaceutical Industries
Modality
Small Molecules
Administration
Oral
01

Overview

T2000 is an investigational, proprietary formulation of sodium oxybate being developed by Sun Pharmaceutical Industries for the treatment of moderate to severe essential tremor. Sodium oxybate is a central nervous system depressant that acts as an agonist at the gamma-aminobutyric acid receptor type B (GABA-B) and the gamma-hydroxybutyrate (GHB) receptor. While sodium oxybate is traditionally approved for the treatment of narcolepsy and cataplexy, T2000 is being evaluated for its potential to reduce tremor amplitude and frequency in patients with essential tremor who have not responded adequately to first-line therapies. The drug is currently in Phase 2 clinical development, including long-term safety and efficacy studies.

Other names
sodium oxybate
02

Targets

Gamma-hydroxybutyrate receptorGABA-B (Gamma-aminobutyric acid receptor type B)

Beyond the preview

Go deeper on T2000.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T2000.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call